Diagnostics

WellRX, Parent Company of Ways2Well and ReviveRX, Acquires Bioreach

WellRX, the parent company of preventative healthcare brands ReviveRX and Ways2Well, announces it has acquired Bioreach, a state-of-the-art bloodwork and genetics laboratory. The acquisition brings advanced blood testing capabilities in-house, streamlining diagnostics and enabling the delivery of innovative health tests across WellRX’s ecosystem, including partner telehealth clinics, weight-loss programs, testosterone therapies, and regenerative medicine services. […]

WellRX, Parent Company of Ways2Well and ReviveRX, Acquires Bioreach Read More »

Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls

Microbiologics, a global biotechnology leader specializing in infectious disease reference materials and contract research services, is excited to announce the acquisition of SensID, a leading manufacturer of reference materials and quality controls for molecular diagnostics with a focus on oncology and precision medicine. Founded in 2015, SensID is based in Rostock, Germany where they will

Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls Read More »

Ambry Genetics Being Acquired by Tempus AI for $600M

Aliso Viejo-based Ambry Genetics Corp., Orange County’s third-largest medical diagnostics and testing company, has entered into an agreement to be acquired for $600 million by Tempus AI Inc., which is using artificial intelligence for precision medicine. “Over the last few years, while other laboratories in our industry suffered from challenging market conditions, Ambry experienced record

Ambry Genetics Being Acquired by Tempus AI for $600M Read More »

LabGenomics USA Completes Acquisition of IMD CLIA Labs

LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This acquisition strengthens LabGenomics’ strategic development and expands its diagnostic services nationwide, particularly in molecular technology. In August 2023, LabGenomics acquired QDx, a pathology-specialized lab on the East Coast, which became

LabGenomics USA Completes Acquisition of IMD CLIA Labs Read More »

Scroll to Top